These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37847417)

  • 1. Nutritional status and its correlation to prognosis of nasopharyngeal carcinoma patients in different ages in China: a multicenter cohort study.
    Jia P; Wu X; Shen F; Xu G; Xu H; Cong M; Song C; Shi H
    Support Care Cancer; 2023 Oct; 31(12):638. PubMed ID: 37847417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of the PDCA cycle in the nutritional management of patients with nasopharyngeal carcinoma.
    Zeng X; Huang X; Wang P; Liao J; Wu L; Liu J; Wu H; Wei R
    Support Care Cancer; 2023 Apr; 31(5):251. PubMed ID: 37036536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
    Duan YY; Deng J; Su DF; Li WQ; Han Y; Li ZX; Huan XZ; Zhu SH; Yang QL; Hu W; Xin MZ; Tang LQ; Mai HQ; Fan YY; He Y
    Support Care Cancer; 2021 Sep; 29(9):5371-5381. PubMed ID: 33686519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy.
    Zhang C; Wang SF; Zhang YL; Teng CX
    BMC Cancer; 2024 Aug; 24(1):1012. PubMed ID: 39148032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
    PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
    Du YY; Luo DH; Sun XS; Tang LQ; Mai HQ; Chen QY; Zhong JH; Mai DM; Zhang WR; Chen WH; Mo HY
    Cancer Med; 2019 Nov; 8(16):6841-6852. PubMed ID: 31513364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
    Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
    Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
    BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma.
    Fang WN; Wu HX; Wu ZP; Fei ZD; Zhao D; Chen F; Lin C; Ma LQ
    Sci Rep; 2024 Aug; 14(1):20229. PubMed ID: 39215059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution.
    Li G; Gao J; Liu ZG; Tao YL; Xu BQ; Tu ZW; Zhang XP; Zeng MS; Xia YF
    Head Neck; 2014 May; 36(5):660-6. PubMed ID: 23606535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
    BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified-Nutrition Index is a Significant Prognostic Factor for the Overall Survival of the Nasopharyngeal Carcinoma Patients who Undergo Intensity-modulated Radiotherapy.
    Hong JS; Hua YJ; Su L; Zhang HR; Lv WL; Chen XY; Tian J; Zhang WJ
    Nutr Cancer; 2017 Oct; 69(7):1011-1018. PubMed ID: 28937797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.
    Kim JS; Keam B; Heo DS; Han DH; Rhee CS; Kim JH; Jung KC; Wu HG
    Cancer Res Treat; 2019 Oct; 51(4):1313-1323. PubMed ID: 30699498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up.
    Wang L; Wu Z; Cheng W; Xie D; Lin F; Xia L; Su Y
    Radiat Oncol; 2021 Nov; 16(1):215. PubMed ID: 34742304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
    Sun XS; Liang YJ; Liu SL; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Tang LQ; Mai HQ
    Cancer Res Treat; 2019 Oct; 51(4):1259-1268. PubMed ID: 30653745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
    Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
    Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study.
    Saboorifar H; Zafarani Y; Gholampour G; Roghani A; Qiu F; Dequaniter D; Yu Q
    Eur Arch Otorhinolaryngol; 2024 Aug; 281(8):4315-4324. PubMed ID: 38642085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.